Share on StockTwits

Equities researchers at Goldman Sachs boosted their price target on shares of IMS Health Holdings (NYSE:IMS) from $25.00 to $26.00 in a research report issued on Tuesday. Goldman Sachs’ target price suggests a potential downside of 0.95% from the stock’s previous close.

A number of other firms have also recently commented on IMS. Analysts at Drexel Hamilton initiated coverage on shares of IMS Health Holdings in a research note on Tuesday. They set a “buy” rating and a $30.00 price target on the stock. Separately, analysts at Mizuho raised their price target on shares of IMS Health Holdings from $29.00 to $31.00 in a research note on Thursday, July 24th. They now have a “buy” rating on the stock. Finally, analysts at Wells Fargo & Co. initiated coverage on shares of IMS Health Holdings in a research note on Wednesday, May 14th. They set an “outperform” rating on the stock. Three equities research analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. The stock has an average rating of “Buy” and an average price target of $27.91.

Shares of IMS Health Holdings (NYSE:IMS) traded down 0.23% on Tuesday, hitting $26.19. The stock had a trading volume of 39,940 shares. IMS Health Holdings has a 52-week low of $21.63 and a 52-week high of $27.64. The stock has a 50-day moving average of $25. and a 200-day moving average of $24.67. The company’s market cap is $8.696 billion.

IMS Health Holdings (NYSE:IMS) last issued its quarterly earnings data on Thursday, July 24th. The company reported $0.39 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.37 by $0.02. The company had revenue of $662.00 million for the quarter, compared to the consensus estimate of $654.92 million. The company’s revenue for the quarter was up 6.1% on a year-over-year basis. On average, analysts predict that IMS Health Holdings will post $1.39 earnings per share for the current fiscal year.

IMS Health Holdings, Inc is a global information and technology services company providing clients in the healthcare industry with comprehensive solutions to measure and improve their performance.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.